HR Execs on the Move

MedImpact

www.medimpact.com

 
MedImpact Healthcare Systems, Inc. is the nation’s largest privately held pharmacy benefit management (PBM) company, serving health plans, self-funded employers and government entities. Our business model is unique: avoiding conflicts of interest by not dispensing drugs. MedImpact is focused on effectively managing client pharmacy benefits to facilitate better trend management and improved outcomes. We work with clients to direct prescribing to the lowest-net-cost, medically appropriate drug. Our number one goal is client satisfaction by providing flexible solutions and consumer-driven products with a focus on lowest net cost and quality outcomes.
  • Number of Employees: 1K-5K
  • Annual Revenue: > $1 Billion
  • www.medimpact.com
  • 10181 Scripps Gateway Ct.
    San Diego, CA USA 92131
  • Phone: 858.566.2727

Executives

Name Title Contact Details
Krista Kelley
Senior Vice President, Sales and Marketing Profile
Dorry Battle
VP, Customer Contact Services Profile
Eric Paczewitz
Vice President, Product Management, Marketing and Innovation Profile
Sanjay Joshi
Vice President Of Product and Technology Profile
James Gollaher
Chief Financial Officer Profile

Similar Companies

Good Night Medical

A Great Day Starts With A Good Night!

Ice Biotech

Ice Biotech, Inc. is a Dundas, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Blue Choice Health Plan

Blue Choice Health Plan is a Columbia, SC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Regional Nursing Services

Regional Nursing Services is a Richmond Hill, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Aratana Terapeutics

Aratana Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on the licensing, development, and commercialization of prescription medicines for pets in the United States and Europe. It develops AT-001, a prostaglandin E receptor 4 antagonist to treat the pain and inflammation associated with osteoarthritis in dogs, as well as for the management of pain in cats; AT-002, a potent and selective ghrelin agonist for the stimulation of appetite in cats and dogs; and AT-003, a bupivacaine liposome injectable suspension to manage post-operative pain in cats and dogs following surgery. The company was founded in 2010 and is headquartered in Kansas City, Kansas.